Share Your Research, Maximize Your Social Impacts
The role of novel risk-scoring systems in predicting the efficacy of immunotherapy
Journal: The Journal of V.N. Karazin Kharkiv National University, series "Medicine" (Vol.52, No. 52)Publication Date: 2025-02-28
Authors : Yu.V. Moskalenko;
Page : 59-68
Keywords : immune checkpoint inhibitors LEM non-small cell lung cancer prediction efficacy;
Source : Download
Find it from : Google Scholar
Abstract
Background. Metastatic non-small cell lung cancer (mNSCLC) remains a significant oncological challenge despite major advancements in treatment with immune checkpoint inhibitors (ICIs). However, some patients resist ICIs, highlighting the need for novel risk-scoring systems to predict immunotherapy efficacy.
Other Latest Articles
- Features of sensitization to food allergens in children who were on BLW supplementation
- Development of a model for prediction of relaxation and progression of hormone-resistant form of endometrial hyperplasia in women of reproductive age
- Morphometric features of the prostate gland in rats with sulpiride-induced hyperplasia after combined administration of vitamin D and saw palmetto fruit extract
- Forensic medical evaluation of fatal cases of gastrointestinal diseases as a marker of the quality of surgical care for children in Ukraine
- Clinical Case of Reactive Arthritis Associated with Y. enterocolitica
Last modified: 2025-05-25 01:13:13